Effect of QCC Activities of Reducing the Occurrence Rate of Adverse Reaction of Subcutaneous Injection with Low Molecular Heparin

  • Daoxiu Zhang Department of Urology
  • Hang Wang, Department of Urology
  • Lin Zhang, Department of Urology
  • Xia Zhou Department of Urology
Keywords: Quality control circle, Low molecular heparin, Subcutaneous injection, Occurrence rate adverse reaction

Abstract

Objective: The application effect of QCC of reducing the occurrence rate of adverse reaction of subcutaneous injection with low molecular heparin.
Methods: Select 278 cases of patients of post operation requiring subcutaneous injection with low molecular heparin to prevent from venous thromboembolism in Urology Department of the First Affiliated Hospital of Zhengzhou University from March 2015 to October 2015. Make the activity theme as reducing the occurrence rate of adverse reaction of low molecular heparin in Urology Department. Statistically analyze the occurrence rate of adverse reaction of patients with low molecular heparin before their improvement. Find out the main factors causing adverse reaction, then make corresponding measures to apply to the QCC group. Compare and analyze the difference of the occurrence rate of adverse reaction of subcutaneous injection with low molecular heparin between the control group and the QCC group before and after the QCC activity.
Results: The occurrence rate of adverse reaction of in-patients of subcutaneous injection with low molecular heparin reduced form 37.20% to 11.31% after the implement of QCC activities, and the discrepancy was statistical significant (P<0.05) with a Percent Goal Met of 103% and a progress rate of 71.47% and also a remarkable improving self-assessment of the QCC members.
Conclusion: QCC activities reduced the occurrence rate of adverse reaction of subcutaneous injection with low molecular heparin in Urology Department, meanwhile improved the quality of care and enhanced the capacity of departmental staff to deal with problems.

Author Biographies

Daoxiu Zhang, Department of Urology

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China

Hang Wang,, Department of Urology

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China

Lin Zhang,, Department of Urology

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China

Xia Zhou, Department of Urology

, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China

Published
2017-04-12